2192 — Medlive Technology Co Income Statement
0.000.00%
Last trade - 00:00- HK$5.95bn
- HK$1.93bn
- CNY558.46m
Annual income statement for Medlive Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 284 | 314 | 412 | 558 | 642 |
| Cost of Revenue | |||||
| Gross Profit | 201 | 213 | 251 | 327 | 385 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 214 | 178 | 159 | 217 | 281 |
| Operating Profit | 70.5 | 136 | 253 | 341 | 361 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 69.9 | 135 | 253 | 340 | 360 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 45.2 | 126 | 252 | 330 | 348 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 40.6 | 117 | 242 | 315 | 334 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 40.6 | 117 | 242 | 315 | 334 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.093 | 0.158 | 0.33 | 0.428 | 0.454 |
| Dividends per Share |